These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11069040)

  • 1. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
    Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
    Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report.
    Ysebaert L; Carli PM; Casasnovas RO; Girodon F; Caillot D; Mugneret F; Maynadié M
    Leukemia; 2001 Oct; 15(10):1673-4. PubMed ID: 11587233
    [No Abstract]   [Full Text] [Related]  

  • 3. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
    Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
    Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifaceted approach to the diagnosis and classification of acute leukemias.
    McKenna RW
    Clin Chem; 2000 Aug; 46(8 Pt 2):1252-9. PubMed ID: 10926919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
    Keung YK; Kaplan B; Douer D
    Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
    Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
    Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications.
    Venditti A; Del Poeta G; Stasi R; Buccisano F; Aronica G; Bruno A; Cox C; Maffei L; Tamburini A; Papa G; Amadori S
    Blood; 1996 Jan; 87(1):418-20. PubMed ID: 8547674
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
    Merle-Béral H; Boucheix C
    Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia.
    Vande Berg BC; Michaux L; Scheiff JM; Malghem J; Lecouvet FE; Bourgois MP; Ferrant A; Michaux JL; Maldague BE
    Radiology; 1996 Nov; 201(2):519-23. PubMed ID: 8888252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
    Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
    Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphology and cytochemistry of acute lymphoblastic leukaemia.
    Löffler H; Gassmann W
    Baillieres Clin Haematol; 1994 Jun; 7(2):263-72. PubMed ID: 7803901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostics and therapy of acute myeloid leukemia].
    Fritsch S; Metzeler K; Hiddemann W; Buske C
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-reduced induction therapy for acute leukaemias decreases both the complete remission (CR) rate and the probability of leukaemia-free survival (LFS).
    Krahl R; Helbig W; Kubel M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):783-6. PubMed ID: 1713882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
    Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage switch and translocation t(9;11) in acute leukemia.
    Van Lierde S; Mecucci C; Casteels-Van Daele M; Van den Berghe H
    Am J Pediatr Hematol Oncol; 1989; 11(1):20-2. PubMed ID: 2712237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
    Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.